Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Truffle Capital is a leading European venture capital firm headquartered in Paris, France, specializing in the creation and development of innovative companies in the Life Sciences and Digital Technology sectors. Founded in 2001, the firm distinguishes itself through an "entrepreneur-investor" model, often acting as a co-founder and providing deep operational support to its portfolio companies. In the healthcare space, Truffle Capital focuses on breakthrough medical devices, biotechnology, and digital health, having backed notable companies such as Abivax, Carmat, and Affluent Medical. The firm manages several hundred million euros in assets and aims to transform scientific discoveries into global commercial successes. By bridging the gap between academic research and industrial development, Truffle Capital plays a critical role in the French and European biotech ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Truffle Venture.